Orion Oyj Class B ORNBV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €35.85
- Day Range
- €35.99–36.63
- 52-Week Range
- €31.86–46.97
- Bid/Ask
- €36.54 / €36.58
- Market Cap
- €5.14 Bil
- Volume/Avg
- 79,369 / 263,090
Key Statistics
- Price/Earnings (Normalized)
- 24.94
- Price/Sales
- 4.07
- Dividend Yield (Trailing)
- 2.26%
- Dividend Yield (Forward)
- 2.26%
- Total Yield
- 2.26%
Company Profile
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Core
- Total Number of Employees
- 3,673
- Website
- https://www.orion.fi
Comparables
Valuation
|
Metric
|
ORNBV
|
OKDAV
|
BEACONPHAR
|
|---|---|---|---|
Price/Earnings (Normalized) | 24.94 | 72.17 | 70.78 |
Price/Book Value | 7.03 | 1.22 | 7.15 |
Price/Sales | 4.07 | 0.14 | 4.81 |
Price/Cash Flow | 20.30 | 9.19 | — |
Price/Earnings
ORNBV
OKDAV
BEACONPHAR
Financial Strength
|
Metric
|
ORNBV
|
OKDAV
|
BEACONPHAR
|
|---|---|---|---|
Quick Ratio | 1.00 | 0.52 | 0.39 |
Current Ratio | 1.78 | 0.77 | 1.22 |
Interest Coverage | 91.53 | −4.02 | 1.76 |
Quick Ratio
ORNBV
OKDAV
BEACONPHAR
Profitability
|
Metric
|
ORNBV
|
OKDAV
|
BEACONPHAR
|
|---|---|---|---|
Return on Assets (Normalized) | 15.32% | −2.60% | 4.32% |
Return on Equity (Normalized) | 26.75% | −13.30% | 10.35% |
Return on Invested Capital (Normalized) | 21.52% | −7.05% | 9.14% |
Return on Assets
ORNBV
OKDAV
BEACONPHAR
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Hdsgrkpvy | Cdqpz | $697.4 Bil | |
JNJ
| Johnson & Johnson | Pkqzhkhc | Qbcp | $353.8 Bil | |
MRK
| Merck & Co Inc | Rmngjms | Lpfyx | $332.3 Bil | |
ABBV
| AbbVie Inc | Ygbgknx | Bgvv | $282.6 Bil | |
AZN
| AstraZeneca PLC ADR | Kwlhmnbtpz | Hqjk | $232.3 Bil | |
NVS
| Novartis AG ADR | Yytcwwtv | Jsfk | $200.1 Bil | |
RHHBY
| Roche Holding AG ADR | Zjhxykcrw | Vpwy | $195.3 Bil | |
AMGN
| Amgen Inc | Dmnbnnbqx | Bpch | $144.5 Bil | |
PFE
| Pfizer Inc | Ptndvfkh | Cgsc | $143.8 Bil | |
SNY
| Sanofi SA ADR | Plqsjqmy | Htcq | $122.2 Bil |